# Imagen Technologies

> Physician-led diagnostic imaging and radiology services supported by proprietary AI and workflow technology.

## Why it is interesting

The financing disclosure concerns capital raised during 2026, rather than a specifically described $100 million round. Its model combines clinical staffing, imaging services and AI development; access to imaging studies is a training-data right, not evidence that a model is trained, validated or clinically deployed.

## Profile

- **Latest funding:** Not publicly disclosed
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** growth
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-21

## Key facts

- November 18, 2026 issuer disclosure: more than $100M in growth capital raised during 2026. Exact transactions, instruments, allocations, valuation and legal closing dates are not specified.
- The issuer says it secured rights to up to 150 million additional imaging studies for AI development; this is access capacity, not a count of studies already used to train a validated model.
- The company identifies Alex Dresner as co-founder and CEO on its leadership page: https://imagen.ai/about.

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 21, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/imagen-technologies-radiology
